Skip to content

Expansion of Integrated AI Solution for Diabetic Retinopathy Screening in Thailand

Expansion of Integrated AI Solution for Diabetic Retinopathy Screening in Thailand: An implementation research

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20220722004
Enrollment
34500
Registered
2022-07-22
Start date
2022-10-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 or 2 diabetes mellitus patients who come for diabetic retinopathy screening Diabetic Retinopathy, Screening, Deep Learning Algorithm, Human Grader

Interventions

Diabetes mellitus patients undergo diabetic retinopathy screening by AI,Diabetes mellitus patients undergo diabetic retinopathy screening by health care personnel
Screening,Screening
AI screening group,Manual screening group

Sponsors

Health Systems Research Institute (HSRI)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Type 1 or 2 diabetes mellitus patients whose name are in primary hospital record 2. No full-time ophthalmologists in those primary hospital 3. Age more than or equal to 18 years 4. Eligible for fundus photo imaging at least 1 eye

Exclusion criteria

Exclusion criteria: 1. Type 1 or 2 diabetes mellitus patients whose name are in primary hospital record that have full-time ophthalmologists 2. Patients who previously diagnosed with other causes of macular edema, for example, Age-related Macular Degeneration, Radiation Retinopathy, Retinal Vein Occlusion etc. 3. History of retinal laser or surgery 4. Other ocular diseases that require referral to ophthalmologists 5. Not eligible for fundus photo imaging for both eyes (any causes)

Design outcomes

Primary

MeasureTime frame
Efficiency and effectiveness of AI in diabetic retinopathy screening Throughout the whole period of study 1.Down time and failure rate of AI system 2. Referral adherance in AI group 3. Cost in development and implement of AI system

Secondary

MeasureTime frame
Satisfaction of patients and health care personnel in AI-based screening At the end of study Questionnaire

Countries

Thailand

Contacts

Public ContactPaisan Ruamviboonsuk

Ophthalmology department

paisan.trs@gmail.com022062900

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026